| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.03 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.32 | 0.03 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.04 |